MaTAR25 is overexpressed in mammary tumors in the MMTV-Neu-NDL (HER2 subtype) model compared to normal mammary epithelial cells and it is also upregulated in luminal and triple-negative subtypes of mammary cancer30. Here, ERBB2 is linked to breast cancer.